CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Early on-treatment HDV-RNA kinetics are not predictive for long-term response to a PEG-IFNa therapy of hepatitis delta
DOI 10.1055/s-0034-1397103
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Wöbse, C Yurdaydin, S Ernst, S Hardtke, B Heidrich, B Bremer, O Keskin, R Idilman, A Koch, MP Manns, H Wedemeyer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: PEG-Interferon alfa (PEG-IFNa) is the only currently available treatment option for hepatitis delta. One main goal of therapy is sustained HDV-RNA suppression which is achieved in less than 30% of cases. In PEG-IFNa therapy of HCV infection, early viral kinetics have high positive and negative predictive values for SVR, allowing individualization of treatment. Similar data are not available for HDV inf…
Zitieren
Zitierempfehlung
M Wöbse, C Yurdaydin, S Ernst, S Hardtke, B Heidrich, B Bremer, O Keskin, R Idilman, A Koch, MP Manns, H Wedemeyer (2015) Early on-treatment HDV-RNA kinetics are not predictive for long-term response to a PEG-IFNa therapy of hepatitis delta. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0034-1397103
Mit CareLit weiterarbeiten